These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 28052030

  • 1. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
    Fujihara S, Morishita A, Ogawa K, Tadokoro T, Chiyo T, Kato K, Kobara H, Mori H, Iwama H, Masaki T.
    Oncotarget; 2017 Jan 31; 8(5):8536-8549. PubMed ID: 28052030
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
    Samukawa E, Fujihara S, Oura K, Iwama H, Yamana Y, Tadokoro T, Chiyo T, Kobayashi K, Morishita A, Nakahara M, Kobara H, Mori H, Okano K, Suzuki Y, Himoto T, Masaki T.
    Int J Oncol; 2017 Dec 31; 51(6):1674-1684. PubMed ID: 29075786
    [Abstract] [Full Text] [Related]

  • 3. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
    Oura K, Tadokoro T, Fujihara S, Morishita A, Chiyo T, Samukawa E, Yamana Y, Fujita K, Sakamoto T, Nomura T, Yoneyama H, Kobara H, Mori H, Iwama H, Okano K, Suzuki Y, Masaki T.
    Oncol Rep; 2017 Nov 31; 38(5):2825-2835. PubMed ID: 29048654
    [Abstract] [Full Text] [Related]

  • 4. Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo.
    Matsui T, Chiyo T, Kobara H, Fujihara S, Fujita K, Namima D, Nakahara M, Kobayashi N, Nishiyama N, Yachida T, Morishita A, Iwama H, Masaki T.
    Int J Mol Sci; 2019 Jun 29; 20(13):. PubMed ID: 31261874
    [Abstract] [Full Text] [Related]

  • 5. Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy.
    Ji S, Tang S, Li K, Li Z, Liang W, Qiao X, Wang Q, Yu S, Ye M.
    Toxicol Appl Pharmacol; 2017 Jul 01; 326():25-33. PubMed ID: 28416456
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro.
    Kobara H, Fujihara S, Iwama H, Matsui T, Fujimori A, Chiyo T, Tingting S, Kobayashi N, Nishiyama N, Yachida T, Tadokoro T, Oura K, Tani J, Fujita K, Nomura T, Yoneyama H, Morishita A, Okano K, Suzuki Y, Mori H, Masaki T.
    Mol Med Rep; 2020 Aug 01; 22(2):1063-1071. PubMed ID: 32626983
    [Abstract] [Full Text] [Related]

  • 7. EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancer.
    Fichter CD, Timme S, Braun JA, Gudernatsch V, Schöpflin A, Bogatyreva L, Geddert H, Faller G, Klimstra D, Tang L, Hauschke D, Werner M, Lassmann S.
    Int J Cancer; 2014 Oct 01; 135(7):1517-30. PubMed ID: 24510732
    [Abstract] [Full Text] [Related]

  • 8. Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
    Fujihara S, Kato K, Morishita A, Iwama H, Nishioka T, Chiyo T, Nishiyama N, Miyoshi H, Kobayashi M, Kobara H, Mori H, Okano K, Suzuki Y, Masaki T.
    Int J Oncol; 2015 May 01; 46(5):2172-80. PubMed ID: 25709052
    [Abstract] [Full Text] [Related]

  • 9. Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4.
    Wen SW, Zhang YF, Li Y, Xu YZ, Li ZH, Lü H, Zhu YG, Liu ZX, Tian ZQ.
    Dig Dis Sci; 2018 Sep 01; 63(9):2285-2293. PubMed ID: 29781054
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR.
    Zhao Y, Shang F, Shi W, Zhang J, Zhang J, Liu X, Li B, Hu X, Wang L.
    Cardiology; 2019 Sep 01; 143(1):1-10. PubMed ID: 31307032
    [Abstract] [Full Text] [Related]

  • 11. Activation of AMPK by Telmisartan Decreases Basal and PDGF-stimulated VSMC Proliferation via Inhibiting the mTOR/p70S6K Signaling Axis.
    Hwang YJ, Park JH, Cho DH.
    J Korean Med Sci; 2020 Sep 07; 35(35):e289. PubMed ID: 32893519
    [Abstract] [Full Text] [Related]

  • 12. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
    Cai X, Hu X, Tan X, Cheng W, Wang Q, Chen X, Guan Y, Chen C, Jing X.
    PLoS One; 2015 Sep 07; 10(7):e0133349. PubMed ID: 26196392
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells.
    Yamana Y, Fujihara S, Kobara H, Oura K, Samukawa E, Chiyo T, Okamura M, Yamana H, Tadokoro T, Fujita K, Morishita A, Iwama H, Masaki T.
    J Cancer Res Ther; 2022 Dec 07; 18(Supplement):S305-S312. PubMed ID: 36510981
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma.
    Hassan MS, Williams F, Awasthi N, Schwarz MA, Schwarz RE, Li J, von Holzen U.
    Sci Rep; 2019 Nov 26; 9(1):17608. PubMed ID: 31772236
    [Abstract] [Full Text] [Related]

  • 17. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X, Xiao XY, Shou QY, Yan JF, Chen L, Fu HY, Wang JC.
    J Ethnopharmacol; 2016 Dec 04; 193():538-545. PubMed ID: 27686271
    [Abstract] [Full Text] [Related]

  • 18. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
    Santander S, Cebrián C, Esquivias P, Conde B, Esteva F, Jiménez P, Ortego J, Lanas A, Piazuelo E.
    Int J Oncol; 2012 Feb 04; 40(2):527-34. PubMed ID: 21971589
    [Abstract] [Full Text] [Related]

  • 19. Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation.
    Kresty LA, Weh KM, Zeyzus-Johns B, Perez LN, Howell AB.
    Oncotarget; 2015 Oct 20; 6(32):33438-55. PubMed ID: 26378019
    [Abstract] [Full Text] [Related]

  • 20. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI, Hong JY, Lee HJ, Bae SY, Jung C, Park HJ, Lee SK.
    PLoS One; 2015 Oct 20; 10(12):e0144368. PubMed ID: 26656173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.